You are here: Home / Protocols

Protocols

EDRN investigators protocols. The following is a list of the EDRN protocols that have been captured and curated. Additional information will be added as it is available. Contact information is provided as part of the detail for each protocol.

Contents

Title Abstract Investigator
MSA Bladder Reference Set Application: Charles Rosser-Hawaii (2014) The goal of this proposal is straightforward. We wish to assay in a discovery set, reference set from EDRN, both PAI-1 and ANG promoters and genes for ... Rosser, Charles J
Methylation & Proteomics-Based Detection of Bladder Cancer Study never Launched Cairns, Paul
Methylation tumor markers in HNPCC Lynch, Henry
Moffitt Imaging Biomarker Validation Center We propose to establish the Moffitt Imaging Biomarker Validation Center (MIBVAC) for the EDRN based on the following backgrounds, expertise, resources, ... Heine, John
Molecular Basis of Barrett's -Associated Carcinogenesis Stass, Sanford
Molecular Genetics of Urinary Bladder Carcinoma Czerniak, Bogdan
Molecular Profiling of Cancer: Identification and Characterization of Candidate Biomarkers and Regulatory Genes. IRBMED # 2001-0155 Chinnaiyan, Arul M.
Molecular Progression of Methylation in Bladder Cancer Sidransky, David
Mutational load distribution analysis (MLDA) in pancreatic cancer Certain p16 mutation carriers showed mutation elevations in the specific Ki-ras and p53 alleles significantly higher than normal, similar to controls with ... Lynch, Henry
NYU Lung Cancer Biomarker Center A. SPECIFIC AIMS 1. To develop and prospectively follow a large cohort at high-risk for lung cancer. Individuals are recruited to one of two different ... Rom, William
Nashville Early Diagnosis Lung Cancer Project Massion, Pierre
National Ovarian Cancer Early Detection Program Blood and Genetics Fishman, David
New Biomarkers & Dysplastic Respiratory Epithelium Not listed
Novel Surveillance Strategies For Hereditary Nonpolyposis Colon Cancer Family Members Lynch, Henry
Novel approaches to study immune responses to post translational modifications for cancer detection We propose to develop a BDL to discover immune-based biomarkers for the detection of breast cancers, based on fundamental tumor-specific changes in protein ... LaBaer, Joshua
Ornithine decarboxylase (ODC) Polymorphism and Breast and Prostate Cancer Helzlsouer, Kathy
Ovarian Cancer Screening Pilot Trial In High Risk Women BACKGROUND: No proven ovarian cancer (OC) screening strategy exists for women who are at increased risk for the disease. A risk of ovarian cancer algorithm ... Lynch, Henry
PASS Reference Set Application: Carroll Univ. of California SF (2012) PC101769 Predicting Prostate Cancer Progression at Time of Diagnosis Carroll, Peter R.
PASS Reference Set Application: Lin UW (2010) TMPRSS2-ERG-PCA-PASS Active surveillance is used to manage low-risk prostate cancer. Both PCA3 and TMPRSS2:ERG are promising biomarkers that may be associated with aggressive ... Lin UW, Daniel W.
PASS Reference Set Application: Lin Univ. of Washington/OPKO (2015) Lin UW, Daniel W.
PASS Reference Set Application: Lin Univ. of Washington/OncoChip (2013) Lin UW, Daniel W.
PASS Reference Set Application: Nelson Fred Hutchinson Cancer Research Center (2013) Telomere Length in men with Prostate Cancer under Active Surveillance Nelson, Peter S
PASS Reference Set Application: Ruth Etzioni-William Beaumont Hospital (2014) Etzioni, Ruth
PASS Reference Set Application: Thompson UT Health Science Center San Antonio (2014) SNPs for PCa Outcome Leach, Robin J
PCA3 Reference Set Application: Samantha Maragh NIST This requested sample cohort is intended to evaluate the potential for two mitochondrial DNA (mtDNA) biomarkers to be used for non-invasive early detection of ... Maragh, Samantha
PCA3 Reference Set Application: T2-Erg-Martin Sanda-Emory (2014) We hypothesize that combining T2:erg (T2:erg) fusion and PCA3 detection in urine collected after digital rectal exam can improve the specificity of identifying ... Sanda, Martin
PCA3 Validation Study and Urinary Reference Set Independent of serum PSA level, PCA3 score will refine the risk of having cancer detected on an extended template prostate biopsy. Wei, John
PLCO Ovarian Phase III Validation Study Our preliminary data indicate that the performance of CA 125 as a screening test for ovarian cancer can be improved upon by additional biomarkers. With ... Cramer, Daniel
PTM Microarray: Request for Year 3 Set-Aside Funds We hypothesize that PTMs on proteins that are secreted by the breast will provide a more sensitive method for detecting breast cancer than analysis of the ... Zangar, Richard (Rick) C.
Pancreatic Cancer Bake Off 2 Brand, Randall E.
Announcement 09/27/2019
Thank you to everyone who made the 11th EDRN Scientific Workshop a success. The next EDRN Steering Committee Meeting is from Tuesday-Thursday, March 31-April 2, 2020 in Tempe, AZ.
Announcement



 
This icon signifies that something is happening and we kindly ask you to please wait